Aventis to speed sale of assets seen as noncore: move is one part of effort to repel hostile takeover by French rival Sanofi

Article Abstract:

Aventis S.A. plans to offload several nonstrategic business units as a move to repel a hostile bid by Sanofi-Synthelabo S.A., valued at euro $46 bil. The business units dropped will likely to consist of older pharmaceutical products or those facing slower growth potential.

Acquisitions & mergers, France, Financial management, Pharmaceutical preparations, Mergers, acquisitions and divestments, Finance, Company acquisition/merger, Sanofi S.A., Aventis S.A., Company business planning, Company financing, AVE

---

ICN shareholder seeks vote to urge sale of company

Article Abstract:

Special Situations Partners Inc. is attempting to convince shareholders to call on ICN Pharmaceuticals Inc. to place itself up for sale. Special Situations owns 4% of ICN.

ICN, Special Situations Partners Inc., Valeant Pharmaceuticals International

---

Carter-Wallace plans to sell itself in two pieces

Article Abstract:

Carter-Wallace Inc. is planning to divest itself in two pieces. The plan gives the company a value of $1.1 billion (1.24 billion euros).

MedPointe Inc., CAR

Similar abstracts:

• Abstracts: Disney's profit falls 12% as core units disappoint. Disney's Web effort has trouble keeping workers on the team
• Abstracts: British Airways decides to sell its Qantas stake. Qantas warning sends share price sliding to 1998 low. Northwest says loss will be more than expected
• Abstracts: Dentsu preparing to go public. Japan discovers brand building. Rubel finds exciting challenges in Japanese marketing
• Abstracts: Europe delays benefits. Africa moves closer to CNS/ATM
• Abstracts: Fragrances and cosmetics in Germany. Fragrances and cosmetics in Spain

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.